Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

Wanbang Biopharmaceuticals Co. LtdWanbang Biopharmaceuticals Co. Ltd
VS
Torrent Pharmaceuticals LtdTorrent Pharmaceuticals Ltd
Wanbang Biopharmaceuticals Co. Ltd

Wanbang Biopharmaceuticals Co. Ltd

经济开发区杨山路, 徐州市, 江苏省, 221004, CN

Last Update: 10/12/2025

View Profile
Between 750 and 799
http://www.chinawanbang.com/
751/1000Fair

The Brief Introduction of Wanbang Biopharmaceuticals Wanbang Biopharmaceuticals (brief in “Wanbang Biopharma”) is the core member of Shanghai Fosun Pharmaceutical (Group) Co., Ltd (brief in “Fosun Pharma”, stock code: 600196-SH, 02196-HK). Wanbang Biopharma was establis...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:12
Subsidiaries:28
12-month incidents
0
Known data breaches
0
Attack type number
0
Torrent Pharmaceuticals Ltd

Torrent Pharmaceuticals Ltd

Torrent Pharmaceuticals Ltd, Ahmedabad, 380015, IN

Last Update: 02/04/2026

View Profile
Between 750 and 799
http://www.torrentpharma.com
789/1000Fair

Torrent Pharma, with annual revenues of more than Rs 10,700 crores, is the flagship Company of the Torrent Group, with group revenues of Rs 41,000 crores. It is ranked 5th in the Indian Pharma Market and is among the Top 5 in the therapeutic segments of Cardiovascular (...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:11,552
Subsidiaries:0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
Wanbang Biopharmaceuticals Co. Ltd

Wanbang Biopharmaceuticals Co. Ltd

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Torrent Pharmaceuticals Ltd

Torrent Pharmaceuticals Ltd

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Wanbang Biopharmaceuticals Co. Ltd in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Torrent Pharmaceuticals Ltd in 2026.

Incidents

Incident History - Wanbang Biopharmaceuticals Co. Ltd (X = Date, Y = Severity)

Wanbang Biopharmaceuticals Co. Ltd cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Torrent Pharmaceuticals Ltd (X = Date, Y = Severity)

Torrent Pharmaceuticals Ltd cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
Wanbang Biopharmaceuticals Co. Ltd

Wanbang Biopharmaceuticals Co. Ltd

Incidents
No explicit notable incidents reported.
Torrent Pharmaceuticals Ltd

Torrent Pharmaceuticals Ltd

Incidents
No explicit notable incidents reported.

FAQ

Between Wanbang Biopharmaceuticals Co. Ltd company and Torrent Pharmaceuticals Ltd company, which one has the best AI Cybersecurity Score ?
Between Wanbang Biopharmaceuticals Co. Ltd company and Torrent Pharmaceuticals Ltd company, which one has experienced more cyber incidents in the past ?
Between Wanbang Biopharmaceuticals Co. Ltd company and Torrent Pharmaceuticals Ltd company, which one has experienced more cyber incidents this year ?
Between Wanbang Biopharmaceuticals Co. Ltd company and Torrent Pharmaceuticals Ltd company, which one has experienced at least one ransomware attack ?
Between Wanbang Biopharmaceuticals Co. Ltd company and Torrent Pharmaceuticals Ltd company, which one has experienced at least one data breach ?
Between Wanbang Biopharmaceuticals Co. Ltd company and Torrent Pharmaceuticals Ltd company, which one has experienced at least one targeted cyberattack ?
Between Wanbang Biopharmaceuticals Co. Ltd company and Torrent Pharmaceuticals Ltd company, which one has experienced at least one vulnerability ?
Between Wanbang Biopharmaceuticals Co. Ltd company and Torrent Pharmaceuticals Ltd company, which one holds the most compliance certifications ?
Between Wanbang Biopharmaceuticals Co. Ltd company and Torrent Pharmaceuticals Ltd company, which one holds the fewest compliance certifications ?
Between Wanbang Biopharmaceuticals Co. Ltd company and Torrent Pharmaceuticals Ltd company, which one has the most subsidiaries ?
Between Wanbang Biopharmaceuticals Co. Ltd company and Torrent Pharmaceuticals Ltd company, which one has the largest number of employees ?
Between Wanbang Biopharmaceuticals Co. Ltd and Torrent Pharmaceuticals Ltd, which company holds both SOC 2 Type 1 certifications ?
Between Wanbang Biopharmaceuticals Co. Ltd and Torrent Pharmaceuticals Ltd, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - Wanbang Biopharmaceuticals Co. Ltd or Torrent Pharmaceuticals Ltd ?
Which company is PCI DSS compliant - Wanbang Biopharmaceuticals Co. Ltd or Torrent Pharmaceuticals Ltd ?
Between Wanbang Biopharmaceuticals Co. Ltd and Torrent Pharmaceuticals Ltd, which company complies with HIPAA regulations for healthcare data ?
Between Wanbang Biopharmaceuticals Co. Ltd and Torrent Pharmaceuticals Ltd, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-26422
SUMMARY

clash-verge-service-ipc before 2.3.0 has a world-reachable IPC endpoint, leading to local privilege escalation.

PUBLISHED
Date2026-06-06
UPDATED
Date2026-06-06
RISK INFORMATION (Score: 8.4)
CVSS3
Base Score: 8.4
Complexity: LOW
CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
2.5
CVE-2026-11441
SUMMARY

A vulnerability was identified in theonedev onedev up to 15.0.5. This vulnerability affects the function canAccessIssue of the file /issues/ of the component Pull Request Handler. Such manipulation of the argument issue leads to improper authorization. It is possible to launch the attack remotely. Upgrading to version 15.0.6 is able to resolve this issue. It is advisable to upgrade the affected component.

PUBLISHED
Date2026-06-06
UPDATED
Date2026-06-06
RISK INFORMATION (Score: 6.3)
CVSS2
Base Score: 6.5
Complexity: LOW
AV:N/AC:L/Au:S/C:P/I:P/A:P
CVSS3
Base Score: 6.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L
CVSS4
Base Score: 5.3
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.4
EXPLOITABILITY
2.8
CVE-2026-11440
SUMMARY

A vulnerability was determined in theonedev onedev up to 15.0.5. This affects an unknown part of the file /repositories/{projectId}/default-branch of the component REST API. This manipulation of the argument project.defaultBranch causes improper authorization. It is possible to initiate the attack remotely. Upgrading to version 15.0.6 is able to mitigate this issue. Upgrading the affected component is advised.

PUBLISHED
Date2026-06-06
UPDATED
Date2026-06-06
RISK INFORMATION (Score: 6.3)
CVSS2
Base Score: 6.5
Complexity: LOW
AV:N/AC:L/Au:S/C:P/I:P/A:P
CVSS3
Base Score: 6.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L
CVSS4
Base Score: 5.3
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.4
EXPLOITABILITY
2.8
CVE-2026-11439
SUMMARY

A vulnerability was found in theonedev onedev up to 15.0.5. Affected by this issue is some unknown functionality of the file /projects/ of the component Parent Project Handler. The manipulation of the argument project.parentId results in improper authorization. The attack may be performed from remote. Upgrading to version 15.0.6 can resolve this issue. It is recommended to upgrade the affected component.

PUBLISHED
Date2026-06-06
UPDATED
Date2026-06-06
RISK INFORMATION (Score: 6.3)
CVSS2
Base Score: 6.5
Complexity: LOW
AV:N/AC:L/Au:S/C:P/I:P/A:P
CVSS3
Base Score: 6.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L
CVSS4
Base Score: 5.3
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.4
EXPLOITABILITY
2.8
CVE-2026-11438
SUMMARY

A vulnerability has been found in theonedev onedev up to 15.0.5. Affected by this vulnerability is an unknown functionality of the file /projects. The manipulation of the argument project.forkedFromId leads to improper authorization. The attack is possible to be carried out remotely. Upgrading to version 15.0.6 addresses this issue. Upgrading the affected component is recommended.

PUBLISHED
Date2026-06-06
UPDATED
Date2026-06-06
RISK INFORMATION (Score: 6.3)
CVSS2
Base Score: 6.5
Complexity: LOW
AV:N/AC:L/Au:S/C:P/I:P/A:P
CVSS3
Base Score: 6.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L
CVSS4
Base Score: 5.3
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.4
EXPLOITABILITY
2.8